Zoomlion Tower Cranes Combine Heavy Lifting and Precision Control for Construction at Height

CHANGSHA, China, Oct. 23, 2026 /PRNewswire/ -- Zoomlion Heavy Industry Science & Technology Co., Ltd. ("Zoomlion") supported the Sept. 29 topping out of the 283-meter Shangri-La-side main tower of China's Lugu Lake Grand Bridge. Two R4300-200 tower cranes served the bridge's main towers. Alongside the company's earlier work on a 380-meter tower in Istanbul, the project demonstrates how heavy lifting capacity, precise controls and customized engineering support construction at height.

Heavy Lifting and Remote Control at Lugu Lake Grand Bridge

Located on the Xichang-Shangri-La Expressway in southwestern China, the bridge required accurate placement of large structural components in a mountain canyon. Each R4300-200 handled component lifting for its respective main tower. The final 103 meters of the Shangri-La-side tower construction included positioning the last steel and concrete sections above the central crossbeam, where changing wind conditions made stability and load control particularly important.

With a maximum lifting capacity of 200 metric tons and an 80-meter jib, the R4300-200 combines heavy lifting performance with more than 20 intelligent safety and control functions. These include collision prevention, automatic adjustment of operating speed according to load and controls that prevent suspended loads from slipping downward. Together, these features support controlled movement and positioning of heavy components during tower assembly.

Live camera feeds allow operators to monitor component positioning and control lifts remotely from ground level. This provides a view of lifting operations and supports accurate alignment during installation. Segment lifting for the Shangri-La-side main tower was completed safely.

Customized Engineering and Coordinated Technical Support in Istanbul

Zoomlion applied a different equipment configuration at the Central Bank of the Republic of Türkiye's tower within the Istanbul International Financial Center. The 380-meter building combined steel framing with precast concrete. Construction required 1,260 heavy lifts, including steel columns weighing up to 48.2 metric tons, within a tightly constrained site.

For this project, Zoomlion customized its L760-50 luffing jib tower crane, which has a maximum lifting capacity of 50 metric tons and a maximum jib length of 60 meters. Modular mast sections measuring 2.3 meters on each side accommodated the limited space and enabled transport in standard shipping containers. Each crane required 10 custom connections to the building, engineered to meet local seismic requirements.

Variable-frequency drives regulate lifting, rotation and jib movement, enabling smooth starts, stops and fine adjustments when aligning heavy steel components. The control system supports precise positioning and helps manage load sway. Wind speed monitoring provides automatic warnings and limits operating speeds when preset thresholds are exceeded, helping teams manage changing conditions at height.

Remote monitoring and maintenance technology complemented these controls by transmitting 28 operating parameters, including loads, component temperatures, operating hours and fault codes. These data supported assessment of component wear and preventive maintenance. Zoomlion's R&D team in China worked remotely with engineers based in Türkiye to diagnose equipment issues and support timely maintenance, helping limit downtime. Equipment selection and technical support helped sustain a construction schedule of one floor every five days for the main structure.

Support also extended to crane placement, installation feasibility studies and dismantling simulations, connecting equipment design with practical construction requirements.

The project demonstrated Zoomlion's capabilities in customization, R&D, rapid delivery and responsive service. It also provided experience for other high-rise projects, including the 377-meter Ciel Dubai Marina hotel, Dubai's 400-meter Al Habtoor Tower and Indonesia's 331-meter Oasis Central Towers.

Building on this experience, Zoomlion will continue to develop tailored lifting solutions with ongoing technical support to meet the demands of high-rise and infrastructure construction.

** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **

Zoomlion Tower Cranes Combine Heavy Lifting and Precision Control for Construction at Height

YICHANG, China, Oct. 23, 2026 /PRNewswire/ -- Angel Yeast (SSE: 600298), one of the world's leading yeast manufacturers, has hosted the 2026 International Synthetic Biology Symposium and the Angel Group High-Quality Development Conference in Yichang, its headquarters city, on October 19–20, 2026, as part of the company's 40th anniversary celebrations.

As a highlight of Angel Yeast's 40th anniversary, the event convened over 500 global industry partners, including academicians, experts, scholars, supplier representatives, and customer delegates from China and abroad. It offered a platform to discuss biomanufacturing and synthetic biology trends, industrial innovation, and global supply chain collaboration, showcasing Angel Yeast's strategy of deepening international cooperation through innovation, openness, and localized operations.

The event was both a celebration of Angel Yeast's journey and a launchpad for global partners to deepen biomanufacturing collaboration and shape future growth together.

At the High-Quality Development Conference, Angel Yeast reflected on its journey from starting as an edible yeast pilot base to becoming the world's second-largest producer by sales volume. Today, its products reach 170+ countries and regions, serving 30,000+ customers worldwide with over 20% market share.

In innovation, Angel Yeast has built an industrial microbial strain bank and mastered key technologies in strain selection, cell factory construction and multi-carbon source fermentation. The company invests over USD 149.8 million in R&D annually, employs more than 1,500 researchers, and collaborates with over 70 research institutes worldwide.

Angel Yeast has cumulatively obtained 534 authorized invention patents, with 12 scientific and technological achievements reaching international leading levels. The company has continuously optimized its market layout and refined a research-and-sales synergy mechanism adapted to its new development stage composing of 4 business segments, 6 overseas business divisions and 8 technology centers.

Globally, Angel Yeast operates a multi-regional production and R&D network. Its Egypt plant, after two expansions, is now the world's largest yeast factory, while its new Indonesia plant is set to begin production in Q1 next year. Overseas factories and subsidiaries employ nearly 2,000 foreign staff, with a localization rate exceeding 95%.

Angel Yeast is committed to a circular economy industrial chain: raw materials sourced from agricultural processing, core products serving food health and safety, and by-products feeding back into agriculture. It has built five National Green Factories and one zero-carbon factory, with its Ecovadis rating in the global top 15%. The company also participates in setting international standards, including the Codex Alimentarius standard for yeast products, driving the coordinated global expansion of its products, technologies, standards, and brand.

"Looking ahead, Angel Yeast will vigorously develop new synthetic biology technologies, focusing on new tracks such as future foods, biomedicine, enzyme catalysis and new materials, and agricultural microbiology. We will build a 'biomanufacturing+' industrial cluster, continuously propel the industrial chain toward the high end of the value chain, and strive to build a world-class biotechnology company," remarked Xiong Tao, Chairman of Angel Yeast.

** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **

Angel Yeast Marks 40th Anniversary, Setting Its Sights on Becoming a Global Biotech Powerhouse